.png){kind=logo}
EMD Serono and SiS Women's Health Launch Groundbreaking Corporate Accelerator Program for Women's Health Innovators
NEW YORK, February 20th, 2025 - SiS: Women's Health, the leading platform accelerating innovation in women's healthcare, announces the launch of the EMD Serono Corporate Accelerator (ESCA) program in conjunction with SiS NewYork 2025. This exclusive opportunity connects breakthrough reproductive health innovators with EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S., a global healthcare leader, and M Ventures, their strategic corporate venture arm.
The one-day intensive program, taking place on May 14th, 2025, during SiS New York, offers selected companies unprecedented access to the global leadership team from Merck KGaA Darmstadt, Germany and M Ventures. Innovators will participate in private pitch sessions, strategic roundtables, and exclusive networking opportunities with key decision-makers.
"Building on the success of our Innovation Challenge in London, which led to three pilot partnerships from over 100 evaluated startups, this expanded collaboration represents a significant evolution," said Nathan Edwards, Founder of SiS: Women's Health. "Having EMD Serono now elevate their commitment by making SiS part of their global innovation scouting network validates our mission to transform the women's health landscape."
Key EMD Serono and M Ventures executives participating:
The program specifically targets innovations in:
Selected companies will benefit from:
- 30-minute private pitch opportunity with EMD Serono and M Ventures leadership
- EMD Serono led roundtable discussions addressing key systemic challenges in women's health
- Exclusive cocktail reception with ESCA participants
The ESCA program is part of SiS New York 2025, the premier women's health innovation summit delivering actionable insights for building investable and scalable businesses. The event features industry-leading speakers, successful case studies, and extensive networking opportunities for innovators, investors, service providers, and multinational corporations. You can visit the event homepage below.
New York event
Important Dates:
Application Deadline: April 17th, 2025
Shortlist Announcement: April 25th, 2025
Program Date: May 14th, 2025
Interested companies can apply using the button below:
APPLY HERE
About SiS (Solve impact Scale)
SiS: Women's Health accelerates innovation through global events, corporate innovation programs, and strategic matchmaking. The platform connects high-potential companies with strategic partners and resources needed to scale, transforming overlooked areas into breakthrough opportunities in the $50B women's health market.
For more information, contact:
info@sis.global